Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Tivdak 40 mg powder for concentrate for solution for infusion {equilateral_black_triangle}

Active Ingredient:
Tisotumab vedotin
Company:  
Genmab A/S See contact details
ATC code: 
L01FX23
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL)
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 03 Feb 2026

{equilateral_black_triangle} This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.

{pdf} View or print the patient leaflet as PDF
Genmab A/S
Company image
Address
Carl Jacobsens Vej 30, Valby, 2500, Denmark
Telephone
+45 7020 2728
Medical Information Direct Line
+44 2045792977
Medical Information e-mail
[email protected]
WWW
www.genmab.com